Medasense’s Pain Assessment Monitor Among Winners Of Biomed Startup Competition

Understanding pain is still a major challenge for millions of doctors and patients around the world: How severe is a patient’s pain? Can the level of pain tell the physician something about the patient’s condition?

An Israeli biomed startup called Medasense has developed a technology that mathematically measures pain in order to give doctors the best assessments. And that’s why last week, the company was announced as one of two winners of the startup competition at the Israel Advanced Technology Industries (IATI) Biomed Conference.

Founded in 2008 by Galit Zuckerman, Medasense’s innovative technology assesses changes in a patient’s level of pain. The company’s flagship product is a non-invasive pain monitoring device that can help clinicians achieve better patient outcomes by accurately adjusting treatment.

Source nocamels